Drug Manufacturing

Moderna to build new mRNA vaccine manufacturing facility in Canada

Biotechnology firm Moderna and Canadian government have signed a memorandum of understanding (MoU) to construct a new messenger RNA (mRNA) vaccine manufacturing facility in Canada.

Amgen to construct new drug substance manufacturing plant in North Carolina

Amgen has announced plans to construct a new multi-product drug substance manufacturing facility in Holly Springs, North Carolina, the US.

Biovac partners with Pfizer and BioNTech to manufacture Covid-19 vaccine

Pfizer and BioNTech have signed a letter of intent with The Biovac Institute, the South African biopharmaceutical company, to jointly manufacture and distribute their Covid-19 Vaccine in the African Union.

Lilly to acquire remaining shares of Protomer Technologies for $1bn

Eli Lilly and Company is set to acquire the remaining shares of biotech firm Protomer Technologies in a deal valued more than $1bn.

RDIF and SII to produce Russian Sputnik V Covid-19 vaccine in India

The Russian Direct Investment Fund (RDIF) has collaborated with Serum Institute of India (SII) to produce Sputnik V Covid-19 vaccine in India.

Philip Morris to acquire inhaled drug provider Vectura Group for $1.2bn

Philip Morris International (PMI) has agreed to acquire British pharmaceutical firm Vectura Group for about $1.183bn (£852m) to expand its product pipeline development capabilities in inhaled therapeutics.

Verge Genomics, Eli Lilly partner to develop ALS therapies

Verge Genomics has announced a three-year partnership with Eli Lilly and Company to discover and develop novel therapies for amyotrophic lateral sclerosis (ALS), a motor neuron disease.

Mexico produces test batch of Sputnik V Covid-19 vaccine

The Russian Direct Investment Fund (RDIF) has announced the production of a test batch of the Russian Covid-19 vaccine, Sputnik V, in Mexico.

Philip Morris to acquire Fertin Pharma for $812.8m

Philip Morris International has signed an agreement to acquire Fertin Pharma from private equity firm EQT for approximately $812.8m (DKK5.1bn).